This is not the most recent version of the article. View current version (22 DEC 2014)

Intervention Protocol

The effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG)

  1. Sylvia Farzi1,*,
  2. Elisabeth Mahla1,
  3. Helfried Metzler1,
  4. Andrea Berghold2

Editorial Group: Cochrane Anaesthesia Group

Published Online: 14 NOV 2012

DOI: 10.1002/14651858.CD010195


How to Cite

Farzi S, Mahla E, Metzler H, Berghold A. The effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG) (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD010195. DOI: 10.1002/14651858.CD010195.

Author Information

  1. 1

    Medical University of Graz, Department of Anesthesiology and Intensive Care Medicine, Graz, Austria

  2. 2

    Medical University of Graz, Institute for Medical Informatics, Statistics and Documentation, Graz, Austria

*Sylvia Farzi, Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, 29, Auenbruggerplatz, Graz, 8036, Austria. sylvia.farzi@medunigraz.at.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

This is not the most recent version of the article. View current version (22 DEC 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective of this review is to assess the effect of P2Y12 receptor inhibitor therapy, administered within the recommended specific preoperative withdrawal period (five days for clopidogrel and ticagrelor, seven days for prasugrel) on in-hospital and 30-day all-cause mortality and perioperative bleeding in CABG patients.